Long-term follow-up after switching from originator infliximab to its biosimilar CT-P13: the weight of nocebo effect
| Image |  |
|---|---|
| Description | article |
| Author/s |
author: Marc Scherlinger |
| Publication date | October 23, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |